150 related articles for article (PubMed ID: 30055965)
21. TGF-β1 induced transdifferentiation of rpe cells is mediated by TAK1.
Dvashi Z; Goldberg M; Adir O; Shapira M; Pollack A
PLoS One; 2015; 10(4):e0122229. PubMed ID: 25849436
[TBL] [Abstract][Full Text] [Related]
22. Analysis of transforming growth factor β signaling in chronic rhinosinusitis.
Li YC; An YS; Wang T; Zang HR
Chin Med J (Engl); 2013; 126(17):3340-3. PubMed ID: 24033961
[TBL] [Abstract][Full Text] [Related]
23. Antagonism of transforming growth factor-Beta signaling inhibits fibrosis-related genes.
Liu XJ; Ruan CM; Gong XF; Li XZ; Wang HL; Wang MW; Yin JQ
Biotechnol Lett; 2005 Oct; 27(20):1609-15. PubMed ID: 16245182
[TBL] [Abstract][Full Text] [Related]
24. Benzalkonium chloride induces subconjunctival fibrosis through the COX-2-modulated activation of a TGF-β1/Smad3 signaling pathway.
Huang C; Wang H; Pan J; Zhou D; Chen W; Li W; Chen Y; Liu Z
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8111-22. PubMed ID: 25406285
[TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1 (TSP-1) analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover active pituitary transforming growth factor-β1 (TGF-β1).
Recouvreux MV; Camilletti MA; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
Endocrinology; 2012 Aug; 153(8):3861-71. PubMed ID: 22700773
[TBL] [Abstract][Full Text] [Related]
26. Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition.
Wang QL; Yuan JL; Tao YY; Zhang Y; Liu P; Liu CH
J Ethnopharmacol; 2010 Feb; 127(3):631-40. PubMed ID: 20015471
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of the TGF-β/Smad3 signaling pathway by SB431542: A study of the intervention effect of SB431542 on silicotic fibrosis in rats].
Zhou QW; Gao FY; Tian D; Liu HR; Wang FX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2019 Nov; 37(11):801-805. PubMed ID: 31826541
[No Abstract] [Full Text] [Related]
28. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
29. Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.
Cai L; Leng ZG; Guo YH; Lin SJ; Wu ZR; Su ZP; Lu JL; Wei LF; Zhuge QC; Jin K; Wu ZB
Endocrine; 2016 Jun; 52(3):641-51. PubMed ID: 26662185
[TBL] [Abstract][Full Text] [Related]
30. The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas.
Recouvreux MV; Camilletti MA; Rifkin DB; Díaz-Torga G
J Endocrinol; 2016 Mar; 228(3):R73-83. PubMed ID: 26698564
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway.
Huang Z; Li S; Fan W; Ma Q
Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277
[TBL] [Abstract][Full Text] [Related]
33. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
Qu Y; Zhang L; Kang Z; Jiang W; Lv C
Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
[TBL] [Abstract][Full Text] [Related]
34. The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment.
Liu YT; Liu F; Cao L; Xue L; Gu WT; Zheng YZ; Tang H; Wang Y; Yao H; Zhang Y; Xie WQ; Ren BH; Xiao ZH; Nie YJ; Hu R; Wu ZB
Acta Neuropathol; 2020 Sep; 140(3):377-396. PubMed ID: 32572597
[TBL] [Abstract][Full Text] [Related]
35. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
36. CTRP6 inhibits fibrogenesis in TGF-β1-stimulated human dermal fibroblasts.
Fan RH; Zhu XM; Sun YW; Peng HZ; Wu HL; Gao WJ
Biochem Biophys Res Commun; 2016 Jul; 475(4):356-60. PubMed ID: 27155158
[TBL] [Abstract][Full Text] [Related]
37. Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas.
Caccavelli L; Morange-Ramos I; Kordon C; Jaquet P; Enjalbert A
J Neuroendocrinol; 1996 Oct; 8(10):737-46. PubMed ID: 8910802
[TBL] [Abstract][Full Text] [Related]
38. Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1.
Krueger C; Hoffmann FM
PLoS One; 2010 Nov; 5(11):e15511. PubMed ID: 21152098
[TBL] [Abstract][Full Text] [Related]
39. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway.
Liu J; Zhuo X; Liu W; Wan Z; Liang X; Gao S; Yuan Z; Wu Y
Chem Biol Interact; 2015 Feb; 227():45-52. PubMed ID: 25559857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
